It is a electrnoics private limited company based in Vihar Near, Delhi, Delhi, India, established in 2019.
2019 | Vihar Near, Delhi, Delhi, India | ActiveNuthelia Pharmaceuticals Private Limited, a active private limited company, was established on 19 August 2019 in Vihar Near, Delhi, Delhi, India. Engaging in repair services within the electrnoics sector, it holds CIN: U52609DL2019PTC353925. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Anant Kumar Agrawal (Director), Vijay Kumar Agrawal (Director). Past directors included Ankit Kumar Shrivastava, Vijay Kumar Agrawal. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at W/O Sh Tej Pal Sharma, E-103-A, F/F, Khno-162/1, Gali No. 3, Ph-1, Bhagirathi, Vihar Near, Delhi, Delhi, 110094.
U52609DL2019PTC353925
353925
19 August 2019
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Nuthelia Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anant Kumar Agrawal | Director | 19 Aug 2019 | Current |
| Vijay Kumar Agrawal | Director | 11 Nov 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Nov 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nuthelia Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 54.92% increase. The company also saw a substantial improvement in profitability, with a 57.87% increase in profit. The company's net worth Soared by an impressive increase of 56.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Nuthelia Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Nuthelia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nuthelia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuthelia Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nuthelia Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was documented.
Progress on Nuthelia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Vijay Kumar Agrawal was appointed as a Director was appointed as a Director on 11 Nov 2022 & has been associated with this company since 3 years 1 month . was recorded as a recent event.
Progress on Anant Kumar Agrawal was appointed as a Director was appointed as a Director on 19 Aug 2019 & has been associated with this company since 6 years 4 months . was documented.
Nuthelia Pharmaceuticals Private Limited was registered on 19 Aug 2019 with Roc Delhi & aged 6 years 4 months as per MCA records. was recorded as a recent event.
The CIN of Nuthelia Pharmaceuticals Private Limited is U52609DL2019PTC353925.
Nuthelia Pharmaceuticals Private Limited is headquartered at W/O Sh Tej Pal Sharma, E-103-A, F/F, Khno-162/1, Gali No. 3, Ph-1, Bhagirathi, Vihar Near, Delhi, Delhi, 110094.
Nuthelia Pharmaceuticals Private Limited was incorporated on 19 August 2019.
The current directors of Nuthelia Pharmaceuticals Private Limited are
The primary industry of Nuthelia Pharmaceuticals Private Limited is Electrnoics.
Nuthelia Pharmaceuticals Private Limited is unlisted.
The authorized capital of Nuthelia Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX